{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T12:40:27Z","timestamp":1777812027673,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["84177"],"award-info":[{"award-number":["84177"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["23\/05"],"award-info":[{"award-number":["23\/05"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jviromet.2024.115034","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T01:57:30Z","timestamp":1726711050000},"page":"115034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Performance of an in-house multiplex PCR assay for HIV-1 drug resistance testing \u2013 A cheaper alternative"],"prefix":"10.1016","volume":"330","author":[{"given":"Tumelo L.","family":"Fortuin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paballo","family":"Nkone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitumetse","family":"Moeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayne","family":"Loubser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline T.","family":"Tiemessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simnikiwe H.","family":"Mayaphi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2024.115034_bib1","unstructured":"UNAIDS. UNAIDS data 2023. 2024. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2023_en.pdf. Accessed on 28 January 2024."},{"key":"10.1016\/j.jviromet.2024.115034_bib2","unstructured":"HSRC. New HIV Survey Highlights Progress and Ongoing Disparities in South Africa\u2019s HIV Epidemic. 2023. Available from: https:\/\/hsrc.ac.za\/press-releases\/hsc\/new-hiv-survey-highlights-progress-and-ongoing-disparities-in-south-africas-hiv-epidemic\/."},{"key":"10.1016\/j.jviromet.2024.115034_bib3","unstructured":"UNAIDS. FAST-TRACK: Ending the AIDS pandemic by 2030. 2023. Available from: https:\/\/www.aidsdatahub.org\/sites\/default\/files\/resource\/unaids-fast-track-ending-aids-epidemic-2030-report.pdf. Accessed on 24 July 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/187152612804142251","article-title":"Adherence to anti-retroviral therapy and its determinants in HIV\/AIDS patients: a review","volume":"12","author":"Emamzadeh-Fard","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.jviromet.2024.115034_bib5","first-page":"282","article-title":"Factors associated with virologic failure in HIV patients on antiretroviral therapy","volume":"46","author":"G\u00f3mez","year":"2022","journal-title":"Farm Hosp."},{"issue":"Suppl 1","key":"10.1016\/j.jviromet.2024.115034_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/QAI.0b013e3180600766","article-title":"The role of adherence to antiretroviral therapy in the management of HIV infection","volume":"45","author":"Conway","year":"2007","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2024.115034_bib7","unstructured":"SADH. 2023 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy and Breastfeeding, Adolescents, Children, Infants and Neonates. 2023. Available from: https:\/\/knowledgehub.health.gov.za\/system\/files\/elibdownloads\/2023-06\/National%20ART%20Clinical%20Guideline%202023_06_06%20version%203%20Web.pdf. Accessed on 20 July 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib8","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1128\/JVI.00495-16","article-title":"HIV-1 protease, reverse transcriptase, and integrase variation","volume":"90","author":"Rhee","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2024.115034_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fmicb.2020.00438","article-title":"Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa","volume":"11","author":"Obasa","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jviromet.2024.115034_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4979252","article-title":"A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples","volume":"2017","author":"Gupta","year":"2017","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.jviromet.2024.115034_bib11","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.2147\/IDR.S388816","article-title":"HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads","volume":"15","author":"Bareng","year":"2022","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.jviromet.2024.115034_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JCM.39.4.1254-1257.2001","article-title":"Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples","volume":"39","author":"Cunningham","year":"2001","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.jviromet.2024.115034_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/JCM.01478-10","article-title":"High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity","volume":"49","author":"Aghokeng","year":"2011","journal-title":"J. Clin. Microbiol"},{"key":"10.1016\/j.jviromet.2024.115034_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jmv.25661","article-title":"Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa","volume":"92","author":"Onoriode Digban","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.jviromet.2024.115034_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198246","article-title":"Genotyping performance evaluation of commercially available HIV-1 drug resistance test","volume":"13","author":"Rosemary","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2024.115034_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/tmi.13851","article-title":"Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data","volume":"28","author":"Delaney","year":"2023","journal-title":"Trop. Med Int Health"},{"key":"10.1016\/j.jviromet.2024.115034_bib17","unstructured":"WHO. Laboratory-based survey of acquired HIV drug resistance using remnant viral load specimens. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240025417. Accessed on 21 October 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13132209","article-title":"Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings","volume":"13","author":"Steegen","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jviromet.2024.115034_bib19","unstructured":"Medical Care Criteria C. New York State Department of Health AIDS Institute Clinical Guidelines. HIV Resistance Assays. Baltimore (MD)2020."},{"key":"10.1016\/j.jviromet.2024.115034_bib20","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/S2352-3018(22)00092-3","volume":"9","author":"Paton","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jviromet.2024.115034_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/QAD.0000000000002936","article-title":"Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen","volume":"35","author":"Keene","year":"2021","journal-title":"Aids"},{"key":"10.1016\/j.jviromet.2024.115034_bib22","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1016\/S2352-3018(22)00136-9","article-title":"Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study","volume":"9","author":"Schramm","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jviromet.2024.115034_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12981-023-00505-3","article-title":"Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings","volume":"20","author":"Manyana","year":"2023","journal-title":"AIDS Res Ther."},{"key":"10.1016\/j.jviromet.2024.115034_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12985-022-01772-8","article-title":"Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages","volume":"19","author":"Nkone","year":"2022","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2024.115034_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/aid.2019.0242","article-title":"The genetic diversity of HIV-1 quasispecies within primary infected individuals","volume":"36","author":"Liu","year":"2020","journal-title":"AIDS Res Hum. Retrovir."},{"key":"10.1016\/j.jviromet.2024.115034_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/CMR.13.4.559","article-title":"Multiplex PCR: optimization and application in diagnostic virology","volume":"13","author":"Elnifro","year":"2000","journal-title":"Clin. Microbiol Rev."},{"key":"10.1016\/j.jviromet.2024.115034_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/COH.0000000000000534","article-title":"HIV subtype diversity worldwide","volume":"14","author":"Bbosa","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jviromet.2024.115034_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep16897","article-title":"History and origin of the HIV-1 subtype C epidemic in South Africa and the greater southern African region","volume":"5","author":"Wilkinson","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2024.115034_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/aid.2020.0160","article-title":"Genetic characterization of HIV-1 Subtype A1\/C\/D\/B\/K unique recombinant form from Eastern Cape, South Africa","volume":"37","author":"Adeniyi","year":"2021","journal-title":"AIDS Res Hum. Retrovir."},{"key":"10.1016\/j.jviromet.2024.115034_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071131","article-title":"Frequent intra-subtype recombination among HIV-1 circulating in Tanzania","volume":"8","author":"Kiwelu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2024.115034_bib31","unstructured":"NDoH. Revised Anti-Retroviral Treatment Guideline Update For Frontline Clinical Health Professionals. 2013. Available from: https:\/\/sahivsoc.org\/Files\/FDC%20Training%20Manual%2014%20March%202013(1).pdf. Accessed on 13 October 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01386-22","article-title":"The G118R plus R263K combination of integrase mutations associated with dolutegravir-based treatment failure reduces HIV-1 replicative capacity and integration","volume":"67","author":"Xiao","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2024.115034_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v15091932","article-title":"Treatment emergent dolutegravir resistance mutations in individuals na\u00efve to HIV-1 integrase inhibitors: a rapid scoping review","volume":"15","author":"Tao","year":"2023","journal-title":"Viruses"},{"issue":"Suppl 1","key":"10.1016\/j.jviromet.2024.115034_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0399-077X(10)70001-9","article-title":"Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor","volume":"40","author":"Delaugerre","year":"2010","journal-title":"Med Mal. Infect."},{"key":"10.1016\/j.jviromet.2024.115034_bib35","unstructured":"SADH. 2019 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy, Adolescents, Children, Infants and Neonates. 2019. Available from: https:\/\/www.nicd.ac.za\/wp-content\/uploads\/2019\/11\/2019-ART-Clinical-Guidelines-25-Nov.pdf. Accessed on 02 February 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib36","unstructured":"WHO. Update of recommendations on first- and second-line antiretroviral regimens. 2019. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325892\/WHO-CDS-HIV-19.15-eng.pdf. Accessed on 09 September 2023."},{"key":"10.1016\/j.jviromet.2024.115034_bib37","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3018(23)00047-4","article-title":"Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study","volume":"10","author":"Dorward","year":"2023","journal-title":"Lancet HIV"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093424001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:05:24Z","timestamp":1777496724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093424001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0166093424001587"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115034","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of an in-house multiplex PCR assay for HIV-1 drug resistance testing \u2013 A cheaper alternative","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2024.115034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115034"}}